1. Home
  2. SHO vs COAG Comparison

SHO vs COAG Comparison

Compare SHO & COAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$11.09

Market Cap

2.0B

ML Signal

HOLD

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$38.25

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
COAG
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
SHO
COAG
Price
$11.09
$38.25
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$9.79
N/A
AVG Volume (30 Days)
1.8M
366.5K
Earning Date
05-05-2026
N/A
Dividend Yield
3.66%
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$1,115,167,000.00
N/A
Revenue This Year
$3.95
N/A
Revenue Next Year
$2.30
N/A
P/E Ratio
$50.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.69
$27.47
52 Week High
$12.07
$55.42

Technical Indicators

Market Signals
Indicator
SHO
COAG
Relative Strength Index (RSI) 55.89 35.66
Support Level $10.99 $29.54
Resistance Level $11.46 $38.87
Average True Range (ATR) 0.18 3.04
MACD 0.03 -0.48
Stochastic Oscillator 89.11 13.71

Price Performance

Historical Comparison
SHO
COAG

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Share on Social Networks: